» Articles » PMID: 1816583

In Vivo Voltammetric Studies on Release Mechanisms for Cocaine with Gamma-butyrolactone

Overview
Publisher Elsevier
Date 1991 Dec 1
PMID 1816583
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of cocaine (20 mg/kg SC) on presynaptic mechanisms of release for dopamine (DA) and for serotonin (5-HT) was studied in nucleus accumbens of unrestrained rats (Rattus norvegicus). The studies were done by assaying synaptic concentrations of DA and 5-HT in the presence of the neuronal impulse flow inhibitor, gamma-butyrolactone (gamma-BL). The results were compared with cocaine effects on accumbens DA and 5-HT in the freely moving rat, without gamma-BL treatment. A neurochemical time course profile showed that the cocaine-induced increase in accumbens synaptic concentrations of DA was significantly blocked (p less than 0.0001) after DA impulse flow was significantly inhibited (p less than 0.0038) by gamma-BL (35.8%). The neurochemical time course profile concurrently showed that the cocaine-induced decrease in accumbens synaptic concentrations of 5-HT was significantly blocked (p less than 0.0004) after impulse flow was significantly inhibited (p less than 0.025) by gamma-BL (50.6%). The findings show that cocaine's effects on synaptic concentrations for DA and for 5-HT in accumbens are dependent on neuronal impulse flow. The findings indicate that presynaptic releasing mechanisms, which may be different for DA vis-à-vis 5-HT, play a role in the mechanism of action of cocaine.

Citing Articles

Development of an Electrochemical Sensor Using a Modified Carbon Paste Electrode with Silver Nanoparticles Capped with Saffron for Monitoring Mephedrone.

Papaioannou G, Karastogianni S, Girousi S Sensors (Basel). 2022; 22(4).

PMID: 35214527 PMC: 8878875. DOI: 10.3390/s22041625.


Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Broderick P, Wenning L, Li Y J Neural Transm (Vienna). 2016; 124(1):57-78.

PMID: 27796511 DOI: 10.1007/s00702-016-1633-3.


Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine.

Broderick P, Kolodny E Pharmaceuticals (Basel). 2016; 2(3):236-249.

PMID: 27713237 PMC: 3978546. DOI: 10.3390/ph2030236.


Sex-specific brain deficits in auditory processing in an animal model of cocaine-related schizophrenic disorders.

Broderick P, Rosenbaum T Brain Sci. 2014; 3(2):504-20.

PMID: 24961412 PMC: 4061862. DOI: 10.3390/brainsci3020504.


Dysfunctional play and dopamine physiology in the Fischer 344 rat.

Siviy S, Crawford C, Akopian G, Walsh J Behav Brain Res. 2011; 220(2):294-304.

PMID: 21335036 PMC: 3081852. DOI: 10.1016/j.bbr.2011.02.009.


References
1.
Porrino L, Ritz M, Goodman N, SHARPE L, Kuhar M, Goldberg S . Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci. 1989; 45(17):1529-35. DOI: 10.1016/0024-3205(89)90418-9. View

2.
Pani L, Kuzmin A, Diana M, de Montis G, Gessa G, Rossetti Z . Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol. 1990; 190(1-2):217-21. DOI: 10.1016/0014-2999(90)94128-k. View

3.
Blaha C, Coury A, Fibiger H, Phillips A . Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis. Neuroscience. 1990; 34(3):699-705. DOI: 10.1016/0306-4522(90)90176-5. View

4.
Aigner T, Balster R . Choice behavior in rhesus monkeys: cocaine versus food. Science. 1978; 201(4355):534-5. DOI: 10.1126/science.96531. View

5.
Walters J, Roth R . Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J Pharmacol Exp Ther. 1974; 191(1):82-91. View